시장보고서

상품코드

1764875

유럽의 장기 보존 용액 시장 : 예측 - 지역별 분석 - 제품, 용도, 유형, 최종 사용자별(-2031년)

Europe Organ Preservation Solution Market Forecast to 2031 - Regional Analysis - by Product, Application, Type, and End User

발행일: 2025년 04월 | 리서치사:

The Insight Partners | 페이지 정보: 영문 140 Pages | 배송안내 : 즉시배송

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유럽의 장기 보존 용액 시장은 2023년에 8,652만 2,540달러로 평가되었고, 2031년에는 1억 5,999만 220달러에 이를 것으로 예측되며, 2024-2031년의 CAGR은 8.1%를 나타낼 전망입니다.

만성 질환 증가가 유럽 장기 보존 용액 시장 공략

선천적 또는 후천성 만성 질환은 시간이 지남에 따라 장기에 손상을줍니다. 이 손상이 환자의 장기 기능에 눈에 띄게 영향을 미치거나 의료적 개입이 필요할 정도로 축적되려면 수십 년이 걸릴 수 있습니다. 만성 간 질환, 예를 들어 지방간 질환과 C형 간염은 만성 간부전의 흔한 원인입니다. 2022년에는 주로 간경변증과 간세포암으로 인해 약 24만 2,000명이 C형 간염으로 사망했습니다. 영국 심장 재단(British Heart Foundation)의 "Global Heart & Circulatory Diseases Factsheet'에 따르면 선천성 심장 질환은 세계 어린이의 건강에 빠르게 대두되는 있는 문제입니다. 선천성 심장병은 전 세계적으로 신생아 110명당 약 1명꼴로 진단됩니다. 신생아 시기 이후에 진단되는 사례까지 포함하면 연간 최대 120만 명에 달할 수 있으며, 이는 하루 평균 3,300명, 즉 26초마다 한 명꼴로 진단이 이루어지는 수치입니다. 따라서 장기 보존 용액 수요는 만성 질환 관련 장기 이식 수술의 가용성에 대한 요구가 급증함에 따라 증가합니다.

유럽 장기 보존 용액 시장 개요

유럽의 장기 보존 용액 시장은 독일, 프랑스, 영국, 스페인, 이탈리아 및 기타 유럽으로 구분됩니다. 향후 몇 년 동안 유리한 기회를 경험할 가능성이 높습니다. 장기 이식 건수 증가, 장기 부전으로 이어지는 만성 질환의 유병률의 상승, 장기 보존 용액의 기술적 진보가 유럽의 장기 보존 용액 시장 성장의 원동력이 되고 있습니다. 세계에서의 장기 보존 용액 시장의 성장에 크게 공헌하는 나라로 기대되고 있습니다. 유엔(UN)의 '세계 인구 고령화(World Population Ageing)' 보고서에 따르면 독일 전체 인구의 약 28.0%가 60세 이상이었으며, 2050년에는 인구 고령화가 약 37.6%로 증가할 것으로 예상됩니다. 만성 질환의 유병률은 연령에 따라 증가합니다.

유럽의 장기 보존 용액 시장의 수익과 2031년까지의 예측(미화 천 달러)

유럽 장기 보존 용액 시장 세분화

유럽의 장기 보존 용액 시장은 제품, 용도, 유형, 최종 사용자, 국가로 분류됩니다.

제품별로 유럽의 장기 보존 용액 시장은 위스콘신 대학 솔루션, 카스토디올 HTK, 퍼파덱스, 하이포서모졸 등으로 분류됩니다.

용도별로 유럽의 장기 보존 용액 시장은 정적 저온 보존, 저체온 기계 관류, 상온 기계 관류 등으로 구분됩니다.

유형별로 유럽의 장기 보존 용액 시장은 신장, 간, 폐, 심장 등으로 분류됩니다. 신장 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.

최종 사용자별로 볼 때 유럽의 장기 보존 용액 시장은 장기 이식 센터, 병원 및 전문 클리닉으로 분류됩니다. 장기 이식 센터 부문은 2023년에 가장 큰 시장 점유율을 차지했습니다.

국가별로 유럽의 장기 보존 용액 시장은 영국, 독일, 프랑스, 이탈리아, 스페인 및 기타 유럽으로 구분됩니다.

XVIVO Perfusion, TransMedics, OrganOx Limited, Paragonix Technologies, Inc, Dr. Franz Koehler Chemie GmbH, Accord Healthcare 등이 유럽의 장기 보존 용액 시장에서 사업을 전개하는 주요 기업입니다.

시장 성장 촉진요인
- 장기 이식 요구 증가
- 만성질환의 유병률 증가
시장 성장 억제요인
- 고액의 장기 이식 수술
- 장기의 가용성 제한
시장 기회
- 시장 진출기업에 의한 전략적 이니셔티브
향후의 동향
- 기계 관류 기술로의 이동
성장 촉진요인과 억제요인의 영향

제5장 장기 보존 용액 시장 : 유럽의 분석

장기 보존 용액 시장의 매출액, 2021-2031년
장기 보존 용액 시장 예측 분석

제6장 유럽 장기 보존 용액 시장 분석 - 제품별

위스콘신 대학 솔루션
카스트디올 HTK
파파덱스
하이포서모졸
기타

제7장 유럽의 장기 보존 용액 시장 분석 - 용도별

정적 냉장 보존
저체온기계 관류
상온기계 관류
기타

제8장 유럽의 장기 보존 용액 시장 분석 - 유형별

신장
간
폐
심장
기타

제9장 유럽 장기 보존 용액 시장 분석 - 최종 사용자별

장기 이식 센터
병원
전문 클리닉

제10장 유럽 장기 보존 용액 시장 분석 - 국가별

유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽

제11장 장기 보존 용액 시장 - 산업 정세

소개
장기 보존 용액 시장의 성장 전략
유기적 성장 전략
무기적 성장 전략

제12장 기업 프로파일

XVIVO Perfusion
TransMedics
OrganOx Limited
Paragonix Technologies, Inc
Dr. Franz Koehler Chemie GmbH
Accord Healthcare

제13장 부록

SHW 25.07.14

The Europe organ preservation solution market was valued at US$ 86,522.54 thousand in 2023 and is expected to reach US$ 1,59,990.22 thousand by 2031; it is estimated to register a CAGR of 8.1% from 2024 to 2031.

Increasing Prevalence of Chronic Disease Fuels Europe Organ Preservation Solution Market

Chronic diseases, which may be congenital or acquired, can lead to gradual damage to organs over time. A chronic disease typically does not resolve on its own, but there may be ways to slow down the damage caused by the condition. It may take decades for this damage to build up to the point where it noticeably affects patients' organ function or requires medical intervention. Chronic kidney disease (CKD) is a common and potentially fatal condition that affects approximately 1 in every 10 people worldwide. Chronic liver diseases such as fatty liver disease and hepatitis C are the common causes of chronic liver failure. The World Health Organization (WHO) estimates that ~50 million people are living with chronic hepatitis C virus infection worldwide, with approximately 1.0 million new infections occurring each year. In 2022, ~242,000 people died from hepatitis C, mainly due to cirrhosis and hepatocellular carcinoma. Chronic heart diseases, including coronary artery disease and congenital heart disease, can lead to progressive heart failure. According to the Global Heart & Circulatory Diseases Factsheet by the British Heart Foundation, congenital heart disease is a rapidly emerging problem in child health worldwide. It is diagnosed in approximately 1 in 110 births globally, and the diagnoses later in the lives of babies may reach as high as 1.2 million per year, averaging 3,300 per day (or a diagnosis every 26 seconds). Thus, the demand for organ preservation solutions increases with a surge in the need for availability of chronic disease-related organ transplantation procedures.

Europe Organ Preservation Solution Market Overview

The Europe organ preservation solution market is segmented into Germany, France, the UK, Spain, Italy, and the Rest of Europe. Germany and Italy are expected to account for a significant market share in the regional market during the forecast period. The market in France, the UK, and Spain is likely to experience lucrative opportunities in the coming years. The growing number of organ transplantations, rising prevalence of chronic diseases that lead to organ failure, and technological advancements in organ preservation solutions drive the organ preservation solution market growth in Europe. Germany is expected to be among the major contributors to the growth of the organ preservation solution market in worldwide. As per the "World Population Ageing," nearly 28.0% of the total population of Germany was aged 60 and above in 2017, and the aging population is estimated to rise to nearly 37.6% by 2050. The prevalence of chronic diseases increases with age. Also, with growing age, many organs start to malfunction or become dysfunctional, giving rise to the demand for organ transplantation procedures. Thus, with the rising geriatric population, the demand for organ preservation solutions is growing.

Europe Organ Preservation Solution Market Revenue and Forecast to 2031 (US$ Thousand)

Europe Organ Preservation Solution Market Segmentation

The Europe organ preservation solution market is categorized into product, application, type, end user, and country.

Based on product, the Europe organ preservation solution market is categorized into University of Wisconsin solution, custodiol HTK, Perfadex, HypoThermosol, and others. The University of Wisconsin segment held the largest market share in 2023.

In terms of application, the Europe organ preservation solution market is segmented into static cold storage, hypothermic machine perfusion, normothermic machine perfusion, and others. The static cold storage segment held the largest market share in 2023.

By type, the Europe organ preservation solution market is categorized into kidneys, liver, lungs, heart, and others. The kidneys segment held the largest market share in 2023.

Based on end user, the Europe organ preservation solution market is segmented into organ transplant centers, hospitals, and specialty clinics. The organ transplant centers segment held the largest market share in 2023.

By country, the Europe organ preservation solution market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe organ preservation solution market share in 2023.

XVIVO Perfusion, TransMedics, OrganOx Limited, Paragonix Technologies, Inc, Dr. Franz Koehler Chemie GmbH, and Accord Healthcare, are among the leading companies operating in the Europe organ preservation solution market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Organ Preservation Solution Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rising Need for Organ Transplantation
- 4.1.2 Increasing Prevalence of Chronic Diseases
4.2 Market Restraints
- 4.2.1 Expensive Organ Transplant Surgeries
- 4.2.2 Limited Organ Availability
4.3 Market Opportunities
- 4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
- 4.4.1 Shift Toward Machine Perfusion Technique
4.5 Impact of Drivers and Restraints:

5. Organ Preservation Solution Market - Europe Analysis

5.1 Organ Preservation Solution Market Revenue (US$ Thousand), 2021-2031
5.2 Organ Preservation Solution Market forecast Analysis

6. Europe Organ Preservation Solution Market Analysis - by Product

6.1 University of Wisconsin Solution
- 6.1.1 Overview
- 6.1.2 University of Wisconsin Solution: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.2 Custodiol HTK
- 6.2.1 Overview
- 6.2.2 Custodiol HTK: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.3 Perfadex
- 6.3.1 Overview
- 6.3.2 Perfadex: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.4 HypoThermosol
- 6.4.1 Overview
- 6.4.2 HypoThermosol: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
6.5 Others
- 6.5.1 Overview
- 6.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

7. Europe Organ Preservation Solution Market Analysis - by Application

7.1 Static Cold Storage
- 7.1.1 Overview
- 7.1.2 Static Cold Storage: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
7.2 Hypothermic Machine Perfusion
- 7.2.1 Overview
- 7.2.2 Hypothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
7.3 Normothermic Machine Perfusion
- 7.3.1 Overview
- 7.3.2 Normothermic Machine Perfusion: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

8. Europe Organ Preservation Solution Market Analysis - by Type

8.1 Kidneys
- 8.1.1 Overview
- 8.1.2 Kidneys: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.2 Liver
- 8.2.1 Overview
- 8.2.2 Liver: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.3 Lungs
- 8.3.1 Overview
- 8.3.2 Lungs: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.4 Heart
- 8.4.1 Overview
- 8.4.2 Heart: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
8.5 Others
- 8.5.1 Overview
- 8.5.2 Others: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

9. Europe Organ Preservation Solution Market Analysis - by End User

9.1 Organ Transplant Centers
- 9.1.1 Overview
- 9.1.2 Organ Transplant Centers: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
9.2 Hospitals
- 9.2.1 Overview
- 9.2.2 Hospitals: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)

10. Europe Organ Preservation Solution Market - Country Analysis

10.1 Europe Organ Preservation Solution Market Overview
- 10.1.1 Europe: Organ Preservation Solution Market Breakdown, by Key Country, 2023 and 2031 (%)
  - 10.1.1.1 Europe: Organ Preservation Solution Market - Revenue and forecast Analysis - by Country
  - 10.1.1.2 Germany: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.2.1 Germany: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.2.2 Germany: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.2.3 Germany: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.2.4 Germany: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.3 United Kingdom: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.3.1 United Kingdom: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.3.2 United Kingdom: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.3.3 United Kingdom: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.3.4 United Kingdom: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.4 France: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.4.1 France: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.4.2 France: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.4.3 France: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.4.4 France: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.5 Italy: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.5.1 Italy: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.5.2 Italy: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.5.3 Italy: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.5.4 Italy: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.6 Spain: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.6.1 Spain: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.6.2 Spain: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.6.3 Spain: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.6.4 Spain: Organ Preservation Solution Market Breakdown, by End User
  - 10.1.1.7 Rest of Europe: Organ Preservation Solution Market - Revenue and forecast to 2031 (US$ Thousand)
    - 10.1.1.7.1 Rest of Europe: Organ Preservation Solution Market Breakdown, by Product
    - 10.1.1.7.2 Rest of Europe: Organ Preservation Solution Market Breakdown, by Application
    - 10.1.1.7.3 Rest of Europe: Organ Preservation Solution Market Breakdown, by Type
    - 10.1.1.7.4 Rest of Europe: Organ Preservation Solution Market Breakdown, by End User

11. Organ Preservation Solutions Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in Organ Preservation Solutions Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 XVIVO Perfusion
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 TransMedics
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 OrganOx Limited
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Paragonix Technologies, Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Dr. Franz Koehler Chemie GmbH
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Accord Healthcare
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms